×
0 0 0 -0.0163934426229508 -0.0490377049180327 -0.0329508196721312 -0.0498360655737705 -0.0165573770491803
Stock impact report

CytRx Corporation Highlights Majority of Cancer Patients Do Not Have Targetable Genetic Mutations and Are Therefore Candidates for Chemotherapy

CytRx Corporation (CYTR)  More Company Research Source: PR Newswire
Last cytrx corporation earnings: 8/9 09:00 am Check Earnings Report
US:NASDAQ Investor Relations: cytrx.com/investors
Impact snapshot Event time: CYTR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
CYTR alerts
from News Quantified
Opt-in for
CYTR alerts

from News Quantified
Opt-in for
CYTR alerts

from News Quantified